Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLC vs GSK✓SelectedUSD · GSKXLC vs GSK performance historyLatest closeAs of+0.30%11/18
Stock and ETF performance explorer

XLC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+54.2%
GSK return
+56.0%
Excess return
-1.7%
Maximum drawdown
-18.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.3%-1.3%+1.6%+0.4%
7D-2.8%-3.1%+0.3%-2.5%
30D-4.1%-0.9%-3.2%-4.0%
3M-4.1%-4.2%0.0%-3.8%
6M-9.2%-1.6%-7.6%-9.1%
YTD-9.5%+2.6%-12.1%-9.7%
1Y-4.4%+6.2%-10.6%-4.8%
All+54.2%+56.0%-1.7%+50.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling